|
Cardiovascular Pharmacology
Citations 41-50 of 92 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Propagermanium Reduces
Atherosclerosis in Apolipoprotein E Knockout Mice via
Inhibition of Macrophage Infiltration
- Tomoya Yamashita, Seinosuke Kawashima, Masanori Ozaki, Masayuki Namiki, Nobutaka Inoue, Ken-ichi Hirata, and Mitsuhiro Yokoyama
Arterioscler Thromb Vasc Biol published April 18, 2002, doi:10.1161/01.ATV.0000019051.88366.9C
[Abstract]
- Thrombosis
Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering
- Roberta Baetta, Marina Camera, Carmen Comparato, Caterina Altana, Michael D. Ezekowitz, and Elena Tremoli
Arterioscler Thromb Vasc Biol 2002;22:692-698; published online before print as doi:10.1161/01.ATV.0000012802.69414.A8
[Abstract]
[Full text]
- Brief Reviews
Pleiotropic Actions of Peroxisome
Proliferator--Activated Receptors in Lipid
Metabolism and
Atherosclerosis
- O. Barbier, I. Pineda
Torra, Y. Duguay, C. Blanquart, J. -C. Fruchart, C. Glineur, and B. Staels
Arterioscler Thromb Vasc Biol published March 14, 2002, doi:10.1161/01.ATV.0000015598.86369.04
[Abstract]
- Articles
Fluvastatin Reduces Tissue
Factor Expression and Macrophage Accumulation in Carotid
Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid
Lowering
- Roberta Baetta, Marina Camera, Carmen Comparato, Caterina Altana, Michael D. Ezekowitz, and Elena Tremoli
Arterioscler Thromb Vasc Biol published February 14, 2002, doi:10.1161/01.ATV.0000012802.69414.A8
[Abstract]
- Atherosclerosis and Lipoproteins
Atorvastatin Preferentially Reduces LDL-Associated Platelet-Activating Factor Acetylhydrolase Activity in Dyslipidemias of Type IIA and Type IIB
- Vasilis Tsimihodimos, Sonia-Athena P. Karabina, Afroditi P. Tambaki, Eleni Bairaktari, John A. Goudevenos, M. John Chapman, Moses Elisaf, and Alexandros D. Tselepis
Arterioscler Thromb Vasc Biol 2002;22:306-311, doi:10.1161/hq0202.102918
[Abstract]
[Full text]
- Vascular Biology
Effect of Angiotensin II Type 1 Receptor Blockade on Cardiac Remodeling in Angiotensin II Type 2 Receptor Null Mice
- Lan Wu, Masaru Iwai, Hironori Nakagami, Rui Chen, Jun Suzuki, Masahiro Akishita, Marc de Gasparo, and Masatsugu Horiuchi
Arterioscler Thromb Vasc Biol 2002;22:49-54, doi:10.1161/hq0102.102277
[Abstract]
[Full text]
- Thrombosis
Pharmacokinetics and Pharmacodynamics of AJW200, a Humanized Monoclonal Antibody to von Willebrand Factor, in Monkeys
- Shunsuke Kageyama, Hiroshi Yamamoto, Harumi Nakazawa, Junko Matsushita, Tetsuya Kouyama, Akinori Gonsho, Yasuo Ikeda, and Ryota Yoshimoto
Arterioscler Thromb Vasc Biol 2002;22:187-192, doi:10.1161/hq0102.101520
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice
- Harry R. Davis, Jr, Douglas S. Compton, Lizbeth Hoos, and Glen Tetzloff
Arterioscler Thromb Vasc Biol 2001;21:2032-2038, doi:10.1161/hq1201.100260
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
- Takaaki Sakai, Vaijinath S. Kamanna, and Moti L. Kashyap
Arterioscler Thromb Vasc Biol 2001;21:1783-1789, doi:10.1161/hq1001.096624
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Bioavailability of Vitamin E as Function of Food Intake in Healthy Subjects: Effects on Plasma Peroxide–Scavenging Activity and Cholesterol-Oxidation Products
- L. Iuliano, F. Micheletta, M. Maranghi, G. Frati, U. Diczfalusy, and F. Violi
Arterioscler Thromb Vasc Biol 2001;21:e34-37e, doi:10.1161/hq1001.098465
[Abstract]
[Full text]
|
|
